• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Ashland advances strategic $60MM network optimization

    7/8/25 5:00:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary
    Get the next $ASH alert in real time by email

    WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today provided an update on its $60 million manufacturing network optimization plan, a key initiative under its "execute" strategy. As part of ongoing efforts to enhance operational consistency and profitability, and improve the competitive position of core technologies, the company announced the closure of its manufacturing facility in Parlin, New Jersey, and the transfer of its hydroxyethyl cellulose (HEC) production from Parlin to its Hopewell, Virginia plant. This action is a critical step in building larger scale, improving costs across manufacturing sites and delivering the planned HEC network optimization savings in line with Ashland's timeline. The company also announced the closure of its Chatham, New Jersey plant, and the transfer of its microbial protection production to its Freetown, Massachusetts plant, making progress on the consolidation of its smaller plants into its larger manufacturing sites. Beyond the network optimization, Ashland continues to invest in its future.

    "Our team has been focused on a deliberate strategy, taking purposeful actions to increase our competitive position," said Guillermo Novo, chair and chief executive officer, Ashland. "With the completion of our portfolio optimization and $30 million restructuring plan, we are now accelerating cost savings from our $60 million manufacturing network optimization. Doing so increases the momentum of our growth plans and builds in optionality for the strategic repurpose and modernization of existing assets while improving our processes. We expect these actions to have a positive impact on our profitability and cost competitiveness, enabling us to gain market share."

    The company's $60 million manufacturing network optimization continues to strengthen core technologies including vinyl pyrrolidone and derivatives (VP&D) and HEC. The Hopewell facility has received increased investments to expand its capacity and capabilities, building scale for the company. This latest update marks the completion of the HEC plans, a vital component of the overall savings initiative. The newly consolidated HEC network has capacity to support demand with production in the United States, Europe, and China. Another critical phase for Ashland is identifying and accelerating productivity for the plant network, to drive savings above the network optimization target of $60 million. Details about these efforts will be shared over time.

    Novo emphasized, "These decisive actions allow us to navigate near-term challenges effectively and position Ashland for enhanced profitability and operating consistency. It's about acting with prudence and discipline, concentrating on our controllable factors to maximize results and deliver on our self-help growth commitments."

    Under its "globalize" strategy, Ashland has made significant investments in Ireland and the United States for its injectables business, in Brazil for its tablet coatings and microbial protection business, in China for its biofunctionals actives business, and in the United States and Europe for microbial protection.   The company is also in the process of building a tablet coating plant in India.

    During a recent Innovation Day for analysts and investors, Ashland showcased enhanced capabilities and expanded applications of its scalable technology platforms. These new-to-the-world, patented technologies can be "tuned" and precisely calibrated for customer and regional preferences, environmental conditions and regulatory considerations, allowing Ashland to unlock new, sizable markets with differentiated performance.

    "Ashland's strategic priorities represent a fundamental shift in how we approach innovation, organic growth, and manufacturing," Novo added. "The portfolio and network optimization efforts provide strategic flexibility for the cost-effective repurposing of assets. This enables de-risked production for our new technology platforms, while combining the efficiency of large-scale operations with the precision of localized customization to serve our customers."

    About Ashland 

    Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 2,960 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com and ashland.com/ESG to learn more.  

    Forward-Looking Statements 



    This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as "anticipates," "believes," "expects," "estimates," "is likely," "predicts," "projects," "forecasts," "objectives," "may," "will," "should," "plans" and "intends" and the negative of these words or other comparable terminology. Ashland may from time to time make forward-looking statements in its annual reports, quarterly reports and other filings with the SEC, news releases and other written and oral communications. These forward-looking statements are based on Ashland's expectations and assumptions, as of the date such statements are made, regarding Ashland's future operating performance, financial, operating cash flow and liquidity, as well as the economy and other future events or circumstances. These statements include but may not be limited to statements with respect to Ashland's expectations regarding its manufacturing network optimization plan.

    Ashland's expectations and assumptions include, without limitation, internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions (such as prices, supply and demand, cost of raw materials, and the ability to recover raw-material cost increases through price increases), and risks and uncertainties affecting Ashland that are described in Ashland's most recent Form 10-K (including Item 1A Risk Factors) filed with the SEC, which is available on Ashland's website at http://investor.ashland.com or on the SEC's website at http://www.sec.gov. Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update any forward-looking statements made in this news release whether as a result of new information, future events or otherwise.

    ™ Trademark, Ashland or its subsidiaries, registered in various countries.

    FOR FURTHER INFORMATION:

    Investor Relations:Media Relations:
    William C. Whitaker Carolmarie C. Brown
    +1 (614) 790-2095+1 (302) 995-3158
    [email protected][email protected]

    Attachment

    • Press_Release_Ashland_Provides_Update_On_Manufacturing_Optimization_20250708


    Primary Logo

    Get the next $ASH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASH

    DatePrice TargetRatingAnalyst
    5/1/2025Overweight → Equal Weight
    Wells Fargo
    3/26/2025$68.00 → $71.00Neutral → Overweight
    Analyst
    3/5/2025Buy → Neutral
    Seaport Research Partners
    8/8/2024$90.00 → $89.00Underweight → Neutral
    JP Morgan
    4/11/2024$100.00 → $112.00Equal Weight → Overweight
    Wells Fargo
    3/14/2024$100.00 → $126.00Hold → Buy
    Jefferies
    3/1/2024$108.00Outperform
    Wolfe Research
    6/29/2023Outperform → In-line
    Evercore ISI
    More analyst ratings

    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chair of the Board and CEO Novo Guillermo bought $2,010,327 worth of shares (31,294 units at $64.24) (SEC Form 4)

      4 - ASHLAND INC. (0001674862) (Issuer)

      2/3/25 4:30:05 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SVP and GM, Life Sciences Assis Alessandra Faccin bought $201,600 worth of shares (3,150 units at $64.00) (SEC Form 4)

      4 - ASHLAND INC. (0001674862) (Issuer)

      2/3/25 4:30:03 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ashland downgraded by Wells Fargo

      Wells Fargo downgraded Ashland from Overweight to Equal Weight

      5/1/25 3:02:01 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland upgraded by Analyst with a new price target

      Analyst upgraded Ashland from Neutral to Overweight and set a new price target of $71.00 from $68.00 previously

      3/26/25 7:45:24 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland downgraded by Seaport Research Partners

      Seaport Research Partners downgraded Ashland from Buy to Neutral

      3/5/25 7:22:09 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ashland advances strategic $60MM network optimization

      WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today provided an update on its $60 million manufacturing network optimization plan, a key initiative under its "execute" strategy. As part of ongoing efforts to enhance operational consistency and profitability, and improve the competitive position of core technologies, the company announced the closure of its manufacturing facility in Parlin, New Jersey, and the transfer of its hydroxyethyl cellulose (HEC) production from Parlin to its Hopewell, Virginia plant. This action is a critical step in building larger scale, improving costs across manufacturing sites and delivering the planned HEC network optimization sa

      7/8/25 5:00:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland hosts Innovation Day for analysts and investors

      Wilmington, Del., May 28, 2025 (GLOBE NEWSWIRE) -- Ashland will host an Innovation Day for analysts and investors at the company's Bridgewater, New Jersey facility on May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required with options to attend via live webcast or in person. To register, visit the following link: registration page Participants will join Ashland's executive and senior technology leaders for an in-depth review of the latest platform developments and their expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key mark

      5/28/25 5:00:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Valvoline Inc. Announces Kevin Willis as Chief Financial Officer

      Valvoline Inc. announces that Kevin Willis will become the Company's next Chief Financial Officer (CFO), effective May 19, 2025Current CFO, Mary Meixelsperger, whose planned retirement was announced October 2024, will remain with the company through a transition periodLEXINGTON, Ky., May 8, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE:VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that Kevin Willis will succeed Mary Meixelsperger as Valvoline Inc.'s Chief Financial Officer effective May 19. Willis brings significant public company experience to Valvoline including capital markets management, financial systems integrations, and operating efficiency im

      5/8/25 6:45:00 AM ET
      $ASH
      $VVV
      Specialty Chemicals
      Consumer Discretionary
      Major Chemicals
      Industrials

    $ASH
    SEC Filings

    See more
    • SEC Form 11-K filed by Ashland Inc.

      11-K - ASHLAND INC. (0001674862) (Filer)

      5/23/25 2:30:08 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 11-K filed by Ashland Inc.

      11-K - ASHLAND INC. (0001674862) (Filer)

      5/23/25 2:29:14 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 11-K filed by Ashland Inc.

      11-K - ASHLAND INC. (0001674862) (Filer)

      5/23/25 2:22:22 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ashland Inc.

      SC 13G - ASHLAND INC. (0001674862) (Subject)

      11/12/24 11:54:03 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Ashland Inc.

      SC 13G/A - ASHLAND INC. (0001674862) (Subject)

      7/10/24 1:14:41 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Ashland Inc. (Amendment)

      SC 13D/A - ASHLAND INC. (0001674862) (Subject)

      4/25/24 4:15:12 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Leadership Updates

    Live Leadership Updates

    See more
    • Ashland announces executive leadership changes

      WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan

      5/5/25 5:00:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

      Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu

      9/3/24 7:00:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

      Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio

      9/3/24 7:00:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Chattopadhyay Sanat

      4 - ASHLAND INC. (0001674862) (Issuer)

      7/2/25 4:30:04 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by Director Bishop Steven D

      4 - ASHLAND INC. (0001674862) (Issuer)

      7/2/25 4:30:05 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by VP, Controller and PAO Richardson Samuel

      4 - ASHLAND INC. (0001674862) (Issuer)

      5/20/25 4:30:20 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Financials

    Live finance-specific insights

    See more
    • Ashland board authorizes quarterly dividend

      WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025. As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of

      5/6/25 5:15:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland reports second quarter fiscal 2025 results and revises full-year outlook

      Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively, "Portfolio Optimization") reduced overall sales by approximately $67 million or 12 percent versus the prior-year quarter. Excluding these initiatives, sales declined five percent.Income from continuing operations of $30 million, or $0.63 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $46 million, or $0.99 per diluted shareNet income of $31 million, or $0.65 per diluted shareAdjusted EBITDA of $108 million, down 14 percent f

      4/30/25 5:01:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

      WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerKevin Willis, senior vice president and chief financia

      4/17/25 6:30:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary